An official website of the United States government
PAR-21-315 - Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Expired NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): HEAL Initiative: Development and Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech | NOT-NS-24-075 | NINDS, NCCIH, NCI, NIA, NIAAA, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIDDK, NIMH | Aug 8, 2024 | Sep 9, 2025 | U44, UG3/UH3 |
| Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech | NOT-NS-23-002 | NINDS, NCCIH, NCI, NEI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIDCR, NIMH | Aug 3, 2022 | Jun 21, 2024 | U44, UG3/UH3 |
| Notice of Special Interest (NOSI): BRAIN Initiative: Translation of Groundbreaking Technologies from Early-stage Development through Early Clinical Study via Blueprint MedTech | NOT-NS-22-052 | NINDS, NIAAA, NIBIB, NCCIH, NEI, NIA, NICHD, OBSSR, NIDCD, NIDA, NIMH | Jan 5, 2022 | Jun 21, 2024 | U44, UG3/UH3 |
| Notice of Special Interest (NOSI) in Migraine and Headache Research | NOT-NS-22-051 | NINDS | Dec 27, 2021 | May 8, 2022 | U01, K01, UG3/UH3, K22, K99/R00, K02, K08, R01, F30, K23, F32, R21, F31, R61/R33 |
| Notice of Special Interest (NOSI) in NINDS mission relevant Pain Research | NOT-NS-22-050 | NINDS | Dec 27, 2021 | May 8, 2022 | K01, UG3/UH3, K99/R00, K22, K08, R01, K02, F30, K23, R21, F32, F31, U01, U24, R61/R33 |
For technical issues E-mail OER Webmaster